Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), June 17, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the ...
21. Data from phase III randomized trials for budesonide (in non-cirrhotic patients) and bezafibrate, both in combination with UDCA, are not yet published; EASL suggests that currently a ...
The European Association for the Study of the Liver (EASL) and the European Organisation for Research and Treatment of Cancer (EORTC) today publish their first joint Clinical Practice Guidelines (CPGs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback